Management of CPPD with Vascular Calcification

Introduction to CPPD Management

The American College of Rheumatology recommends prioritizing symptomatic treatment of CPPD arthropathy while aggressively managing underlying cardiovascular and renal risk factors according to established guidelines for these comorbidities in older patients with knee X-ray showing CPPD and vascular calcification 1, 2

The European League Against Rheumatism suggests that intra-articular corticosteroid injection is the optimal first-line treatment for monoarticular disease, combined with joint aspiration, ice application, and temporary rest 3, 4
For polyarticular disease or when injection is not feasible, the American College of Rheumatology recommends using oral prednisone 0.5 mg/kg/day for 5-10 days then discontinue, or full dose for 2-5 days then taper over 7-10 days 3
Systemic steroids provide the best benefit-risk ratio in older patients with renal impairment and vascular disease, as NSAIDs carry significant cardiovascular and renal toxicity risks 3

The American College of Rheumatology recommends using low-dose colchicine 0.5-1.0 mg daily for prophylaxis against recurrent attacks in patients with recurrent flares and renal function permits (CrCl >50 mL/min) 3, 4

The National Kidney Foundation recommends assessing for CKD-Mineral Bone Disorder by checking serum calcium, phosphorus, PTH, 25-hydroxyvitamin D, and renal function to identify CKD-associated mineral metabolism disturbances 6
Vascular calcification in CKD results from calcium-phosphate deposition (hydroxyapatite crystals), distinct from CPP crystal deposition in joints 7
Patients with CPPD have 3-fold increased odds of primary hyperparathyroidism (OR=3.03, 95% CI 1.15-8.02) 2

The American College of Rheumatology recommends using methotrexate 5-10 mg/week as second-line treatment for refractory disease (NNT=2 for clinical response in uncontrolled trial) 8
Alternative second-line treatment is hydroxychloroquine (NNT=2, 95% CI 1-7 for >30% reduction in swollen/tender joints) 2, 8

The American College of Rheumatology recommends never using NSAIDs in patients with vascular calcification and likely cardiovascular/renal disease due to high risk of gastrointestinal bleeding, cardiovascular events, and renal impairment 3
Always exclude septic arthritis before injecting steroids, particularly in monoarticular presentations 3

The National Kidney Foundation recommends monitoring renal function, electrolytes, and mineral metabolism parameters regularly 7, 6
Assess for development of chronic inflammatory arthritis or erosive changes 8
Screen for fracture risk given the overlap between CKD-associated osteoporosis and CPPD 6
Consider cardiovascular imaging to assess extent of vascular calcification and guide cardiovascular risk management 6